Our company
Paxman are global leaders in chemotherapy side effect management, on an ambitious journey to help reduce the emotional and physical side effects of cancer treatment.
Over 20 million people and their families face the life-altering impact of cancer each year.
Paxman exists to give them access and choice to proven side effect management solutions, supporting patients worldwide to manage chemotherapy-induced alopecia (CIA) and chemotherapy-induced peripheral neuropathy (CIPN).
Our vision is a world where CIA and CIPN are no longer an issue. Where everyone – regardless of geography, ethnicity, financial situation, gender or treatment regimen – has access to the effective, trusted cryotherapy solutions they need to help prevent the side effects of chemotherapy.
We understand how important consistency, privacy and control are to a patient facing cancer.
Paxman as a company was born out of a husband’s desire to prevent his wife from suffering through the trauma of chemotherapy-induced hair loss. Our founder and chairman Glenn Paxman, along with his brother, Neil Paxman, used their knowledge and expertise in the refrigeration industry to pioneer a scalp cooling system that enables people going through chemotherapy treatment to maintain their hair.
The family mentality of caring and supporting those going through what can be traumatic treatment side effects is maintained to this day and has become a core value as Paxman continues to grow.
Our global team of over 150 individuals is dedicated to improving the patient experience for the better.
The breadth of medical device expertise in our senior leadership team provides strategic direction in all aspects of our mission – from research & development and quality control, to operations and market access.
Memberships & Accreditations
Where to find us next
Catch us at oncology conferences and events around the world. Stop by, say hello, and learn how our technology supports better outcomes for patients.
Paxman careers
Together, we can make a difference.
As a company, we are committed to fostering a positive workplace culture through a proactive approach to investing in people, their wellbeing, and their development via a range of initiatives.
Invested in side effect management
With systems installed in over 65 markets worldwide, Paxman has experienced successful market growth in recent years, placing the company in a strong financial position.
By investing in Paxman, you’re not just supporting a company; you’re joining us in reducing the emotional and physical side effects of cancer treatment.
